Lung Cancer (NSCLC) Clinical Trials

0 recruiting

Showing 120 of 32 trials

Recruiting
Phase 2

Study to Evaluate the Efficacy and Safety of Adjuvant Tislelizumab in High-Risk Stage I NSCLC

Lung Cancer (NSCLC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences108 enrolled1 locationNCT07120282
Recruiting
Not Applicable

Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy

Lung Cancer (NSCLC)Geriatric AssessmentStereotactic Body Radiation Therapy (SBRT)
Brigham and Women's Hospital64 enrolled1 locationNCT06987890
Recruiting
Not Applicable

Engagement of Veterans With Lung Cancer

Lung AdenocarcinomaLung Cancer (NSCLC)
Palo Alto Veterans Institute for Research194 enrolled1 locationNCT07219251
Recruiting
Phase 2

Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer

Lung Cancer (NSCLC)
Chinese University of Hong Kong64 enrolled1 locationNCT07379476
Recruiting
Phase 1

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Pancreatic CancerNon-small Cell Lung Cancer (NSCLC)Pancreatic Ductal Adenocarcinoma (PDAC)+7 more
Revolution Medicines, Inc.574 enrolled5 locationsNCT07349537
Recruiting
Phase 1

A Study of PHN-012 in Patients With Advanced Solid Tumors

Pancreatic CancerColon CancerAdvanced Cancer+2 more
Pheon Therapeutics165 enrolled7 locationsNCT07127874
Recruiting
Phase 1

A Study of SH009 Injection in Patients With Advanced Solid Tumors.

Esophageal CancerBreast Cancer (Locally Advanced or Metastatic)Lung Cancer (NSCLC)+4 more
Nanjing Sanhome Pharmaceutical, Co., Ltd.150 enrolled1 locationNCT07390838
Recruiting
Phase 2

A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer

Lung Cancer (NSCLC)
Sun Yat-sen University56 enrolled1 locationNCT07103395
Recruiting
Phase 1

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Esophageal CancerProstate CancerLung Cancer (NSCLC)+1 more
Phrontline Biopharma200 enrolled7 locationsNCT07181473
Recruiting
Phase 2Phase 3

High Dose Dexamethasone to Reduce Postoperative Pain After Video-Assisted Thoracoscopic Surgery Lobectomy /Segmentectomy

Lung Cancer (NSCLC)AnalgeticVideo Assisted Thoracic Surgery (VATS)+1 more
Rigshospitalet, Denmark80 enrolled1 locationNCT07213375
Recruiting

The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling

Ovarian CancerBrest CancerProstate Cancers+2 more
Javier Toledo6,000 enrolled4 locationsNCT06717295
Recruiting

Tumors and Respiratory System Diseases Due to Air Pollution: New Biomarkers of Exposure and Effects

LeukemiaLung Cancer (NSCLC)COPD
IRCCS Azienda Ospedaliero-Universitaria di Bologna300 enrolled3 locationsNCT06800586
Recruiting

Application of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer

Lung Cancer (NSCLC)
Beijing Haidian Hospital30 enrolled1 locationNCT07257458
Recruiting

Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy

Lung Cancer (NSCLC)
Beijing Haidian Hospital30 enrolled1 locationNCT07257471
Recruiting
Phase 2

A Study of Orally Administered JBI-802 Alone or in Combination With Pembrolizumab for Patients With Non-small Cell Lung Cancer With an STK11 Mutation.

Lung Cancer (NSCLC)
The Christ Hospital30 enrolled1 locationNCT07207395
Recruiting
Phase 2

DC/NK Cell Therapy

Lung Cancer (NSCLC)
National Taiwan University Clinical Trial Center10 enrolled1 locationNCT07202611
Recruiting
Phase 2

Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)

Lung Cancer (NSCLC)
University Hospital, Essen20 enrolled4 locationsNCT06784791
Recruiting
Not Applicable

Selective Lymph Node Resection for Invasive Non-small Cell Lung Cancer With the CTR of 0.5-1 and the Diameter of ≤ 2 cm

Lung Cancer (NSCLC)Lymph Node Dissection
Fudan University684 enrolled1 locationNCT06634979
Recruiting

Inflammation, Cachexia and Therapeutic Response in Lung Cancer Treated With Immune Checkpoint Inhibitors: Exploratory Observational Study

Lung Cancer (NSCLC)
University Hospital, Tours150 enrolled1 locationNCT07004868
Recruiting
Not Applicable

Exercise and Nutrition on Early-stage NSCLC Outcomes: the STARLighT Study

Lung Cancer (NSCLC)
Universita di Verona324 enrolled1 locationNCT07042724